1. Home
  2. YMAB vs WSBF Comparison

YMAB vs WSBF Comparison

Compare YMAB & WSBF Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • YMAB
  • WSBF
  • Stock Information
  • Founded
  • YMAB 2015
  • WSBF 1921
  • Country
  • YMAB United States
  • WSBF United States
  • Employees
  • YMAB N/A
  • WSBF N/A
  • Industry
  • YMAB Biotechnology: Pharmaceutical Preparations
  • WSBF Savings Institutions
  • Sector
  • YMAB Health Care
  • WSBF Finance
  • Exchange
  • YMAB Nasdaq
  • WSBF Nasdaq
  • Market Cap
  • YMAB 218.4M
  • WSBF 233.0M
  • IPO Year
  • YMAB 2018
  • WSBF N/A
  • Fundamental
  • Price
  • YMAB $4.04
  • WSBF $12.42
  • Analyst Decision
  • YMAB Buy
  • WSBF
  • Analyst Count
  • YMAB 11
  • WSBF 0
  • Target Price
  • YMAB $18.73
  • WSBF N/A
  • AVG Volume (30 Days)
  • YMAB 204.4K
  • WSBF 61.4K
  • Earning Date
  • YMAB 05-13-2025
  • WSBF 04-22-2025
  • Dividend Yield
  • YMAB N/A
  • WSBF 4.82%
  • EPS Growth
  • YMAB N/A
  • WSBF 95.86
  • EPS
  • YMAB N/A
  • WSBF 1.02
  • Revenue
  • YMAB $87,685,000.00
  • WSBF $133,551,000.00
  • Revenue This Year
  • YMAB N/A
  • WSBF N/A
  • Revenue Next Year
  • YMAB $18.83
  • WSBF N/A
  • P/E Ratio
  • YMAB N/A
  • WSBF $12.05
  • Revenue Growth
  • YMAB 3.38
  • WSBF 1.81
  • 52 Week Low
  • YMAB $3.84
  • WSBF $11.61
  • 52 Week High
  • YMAB $17.47
  • WSBF $16.86
  • Technical
  • Relative Strength Index (RSI)
  • YMAB 42.87
  • WSBF 48.66
  • Support Level
  • YMAB $4.02
  • WSBF $12.18
  • Resistance Level
  • YMAB $4.60
  • WSBF $12.50
  • Average True Range (ATR)
  • YMAB 0.32
  • WSBF 0.31
  • MACD
  • YMAB -0.01
  • WSBF 0.08
  • Stochastic Oscillator
  • YMAB 23.93
  • WSBF 66.67

About YMAB Y-mAbs Therapeutics Inc.

Y-mAbs Therapeutics Inc is a commercial-stage biopharmaceutical company. It is mainly engaged in the development and commercialization of novel, antibody-based therapeutic products for the treatment of cancer. DANYELZA, is the first FDA-approved product of the company which is a recombinant humanized immunoglobulin G, subtype 1k, or IgG1k, monoclonal antibody or mAb that targets ganglioside GD2, which is expressed in various neuroectoderm-derived tumors and sarcomas.

About WSBF Waterstone Financial Inc. (MD)

Waterstone Financial Inc is a holding company. Through its subsidiaries, It operates in two segments: Community Banking and Mortgage Banking. The community banking segment provides consumer and business banking products and services to customers, which include various types of loans, deposits, and personal investment services. The Mortgage Banking segment involves residential mortgage loans for the primary purpose of sale in the secondary market. The vast majority of its revenue comes from the community banking segment.

Share on Social Networks: